Welcure Drugs & Pharmaceuticals share price
BSE: 524661Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹0.20.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹22 Cr3,646th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- No recent results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- No recent results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, BSEVolume. Shares traded on the last trading day.
- 76,25,873
Results
Standalone; ₹ crore, the charts by years to March, the table by quarter.Quarterly results
Quarter to Mar 2026, against the quarter beforeFiled 29 May
- RevenueRevenue. Under it, revenue in the quarter before. A change in per cent is not worked out where either period is a loss or nothing.
- ₹0.00 CrQuarter to Dec 2025: ₹0.00 Cr
- Net profit
- −₹50 Cr
Revenue by year
Net profit by year, a loss in red
- Net profit
- Loss
The years either side of a change of basis do not compare. From the year to Mar 2025, the company's revenue for that year, ₹25 Cr, differs from its quarters added, ₹55 Cr.
| ₹ crore | Jun 2024Filed 20 Aug | Sep 2024Filed 15 Nov | Dec 2024Filed 15 Feb | Mar 2025Filed 13 Jun | Jun 2025Filed 5 Aug | Sep 2025Filed 13 Nov | Dec 2025Filed 12 Feb | Mar 2026Filed 29 May |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 25 | 9 | 21 | 300 | 66 | 0 | 0 |
| Net profit | 0 | 2 | 0 | 3 | 23 | 9 | 1 | −50 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | – | 7.5% | 4.7% | 12.0% | 7.8% | 13.0% | – | – |
The quarters either side of a change of basis do not compare. From the quarter to Mar 2025, the company's revenue for the year to Mar 2025, ₹25 Cr, differs from its quarters added, ₹55 Cr.
Business segments
One segment, Agriculture, carries all the revenue in the year to Mar 2026.
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −71.0% | – | – | 0.0% |
| 3 years | −13.1% | – | – | 0.0% |
| 5 years | +7.0% | – | – | 0.0% |
Peers and competitors
Pharmaceuticals, 216 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Welcure Drugs & Pharmaceuticals in market cap. 2 companies in the table last traded before then: their rows are priced on their last trade.
Welcure Drugs & Pharmaceuticals is not on the chart: it has no P/E or return on equity today
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Bacil PharmaBACPHAR | 29 | – | 1.1 | – | – | – | – | −0.7% | 0.00% |
 Gujarat Terce LaboratoriesGUJTERC | 27 | 12.7 | 2.7 | 7.6 | −7.2% | – | 25.8% | 25.8% | 0.00% |
 Lasa SupergenericsLASA | 25 | – | 0.5 | – | −95.2% | – | −24.8% | −24.8% | 0.00% |
 Walpar NutritionsWALPAR | 25 | 9.9 | 1.3 | – | +9.8% | −42.7% | 14.0% | – | 0.00% |
 Ishita Drugs & IndustriesISHITADR | 21 | 29.6 | 1.8 | 24.8 | −28.6% | −31.0% | 6.3% | 5.3% | 0.00% |
 Centuple GlobalCENTUPLE | 20 | 16.4 | 9.8 | 13.4 | +4,540.6% | +1,281.3% | 94.1% | 22.8% | 0.00% |
 Zenith Health CareZENITHHE | 17 | 107.1 | 2.3 | 97.9 | −9.3% | – | 2.2% | −1.2% | 0.00% |
 Colinz LaboratoriesCOLINZ | 17 | 6.1 | 1.7 | 26.5 | −8.4% | +484.3% | 28.7% | 1.7% | 0.00% |
Latest announcements
Routine notices left out.Share news and announcements
Jul 2026
Jun 2026
19 Jun · Board meeting
Meeting on 19 Jun 202619 Jun · Management
May 2026
Welcure Drugs & Pharmaceuticals share price by year
Each calendar year to 2025.Welcure Drugs & Pharmaceuticals share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 0.42 | −60.4% | 1.44 | 0.41 |
| 2024 | 1.06 | +203.1% | 1.37 | 0.34 |
| 2023 | 0.35 | −31.0% | 0.51 | 0.32 |
| 2022 | 0.51 | −26.2% | 1.05 | 0.42 |
| 2021 | 0.69 | +240.5% | 1.05 | 0.17 |
| 2020 | 0.20 | +353.1% | 0.21 | 0.03 |
| 2019 | 0.04 | −5.8% | 0.06 | 0.04 |
| 2018 | 0.05 | −53.2% | 0.13 | 0.05 |
| 2017 | 0.10 | −70.4% | 0.42 | 0.08 |
| 2016 | 0.34 | +47.6% | 0.38 | 0.10 |
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 23 Oct 2026 | 0.19 | 0.20 | 0.17 | 0.18 | 0.18 | 76,25,873 |
| 22 Oct 2026 | 0.19 | 0.20 | 0.19 | 0.20 | 0.19 | 18,14,143 |
| 21 Oct 2026 | 0.20 | 0.21 | 0.19 | 0.19 | 0.20 | 58,42,866 |
| 19 Oct 2026 | 0.20 | 0.21 | 0.19 | 0.19 | 0.20 | 25,11,224 |
| 16 Oct 2026 | 0.20 | 0.21 | 0.19 | 0.20 | 0.20 | 35,63,086 |
| 15 Oct 2026 | 0.20 | 0.21 | 0.20 | 0.20 | 0.20 | 45,20,170 |
| 14 Oct 2026 | 0.21 | 0.21 | 0.20 | 0.20 | 0.20 | 33,98,787 |
| 13 Oct 2026 | 0.21 | 0.21 | 0.20 | 0.20 | 0.20 | 22,42,207 |
| 12 Oct 2026 | 0.20 | 0.21 | 0.19 | 0.20 | 0.20 | 74,33,481 |
| 9 Oct 2026 | 0.20 | 0.21 | 0.20 | 0.20 | 0.21 | 66,94,764 |
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Bonus shares and stock split history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 16 Oct 2025 | Bonus | 0.9091 | Holders received 1 bonus share for every 10 held. |
| 16 Oct 2025 | Split | 0.1000 | Each share became 10. |
Company details
- Legal name
- Welcure Drugs & Pharmaceuticals ltd
- BSE code
- 524661
- ISIN
- INE331C01025
- Industry
- Pharmaceuticals & Biotechnology
- Listed
- Oct 1994
- Face value
- ₹1
- CIN
- L24232DL1996PLC227773
- Corporate identity number, the registrar of companies' code for it